To evaluate safety and efficacy of ziv-aflibercept (Zaltrap) in the treatment of refractory diabetic macular edema (DME).
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 20 Sep 2017 New trial record